Outlook Therapeutics (OTLK) Stock Chart & Stock Price History $1.82 -0.08 (-3.95%) As of 02:28 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Outlook Therapeutics Stock Price Performance The Outlook Therapeutics (OTLK) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 74.19%, with a year-to-date return of -3.44%. In the past month, the stock has increased 18.89%, reflecting recent market activity. As of the latest close, Outlook Therapeutics traded at $1.90 with a market cap of $63.78 million and volume of 612,250 shares. Five years ago, the stock traded at a split-adjusted price of $22.40, representing a 91.85% decrease over that period. At the time, it had a market cap of $103.26 million and a volume of 58,814 shares. Receive OTLK Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Outlook Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-2.41%1 Month Performance+18.89%3 Month Performance+29.43%Year-To-Date Performance-3.44%1 Year Performance-74.19%5 Year Performance-91.85% OTLK Stock Chart for Tuesday, June, 10, 2025 OTLK Chart by TradingView Outlook Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/09/2025$1.90$1.90$1.94$1.85612,250 shs$63.78 million06/06/2025$1.87$1.90+1.60%$1.95$1.85663,369 shs$63.78 million06/05/2025$1.91$1.87-2.09%$1.97$1.82859,894 shs$62.77 million06/04/2025$1.85$1.91+3.24%$1.91$1.78704,167 shs$64.12 million06/03/2025$1.77$1.85+4.52%$1.94$1.75923,434 shs$62.10 million06/02/2025$1.85$1.77-4.32%$1.90$1.741.78 million shs$59.42 million05/30/2025$1.80$1.85+2.78%$1.90$1.741.21 million shs$62.10 million05/29/2025$1.63$1.80+10.43%$1.82$1.601.36 million shs$60.42 million05/28/2025$1.61$1.63+1.24%$1.63$1.55215,389 shs$54.72 million05/27/2025$1.60$1.61+0.63%$1.70$1.57763,620 shs$54.04 million Get the Latest News and Ratings for OTLK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Outlook Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/26/2025$1.60$1.60$1.73$1.471.86 million shs$53.71 million05/23/2025$1.64$1.60-2.44%$1.73$1.471.86 million shs$52.19 million05/22/2025$1.63$1.64+0.61%$1.67$1.55742,903 shs$53.50 million05/21/2025$1.70$1.63-4.12%$1.73$1.59889,881 shs$53.17 million05/20/2025$1.76$1.70-3.41%$1.78$1.66598,499 shs$55.45 million05/19/2025$1.75$1.76+0.57%$1.77$1.67621,543 shs$57.41 million05/16/2025$1.68$1.75+4.48%$1.80$1.65320,920 shs$56.03 million05/15/2025$1.75$1.68-4.29%$1.79$1.62304,295 shs$53.63 million05/14/2025$2.03$1.75-13.79%$2.03$1.72932,439 shs$56.03 million05/13/2025$1.59$2.03+27.67%$2.04$1.571.77 million shs$65.00 million05/12/2025$1.54$1.59+3.58%$1.63$1.53752,877 shs$50.91 million05/09/2025$1.44$1.54+6.60%$1.54$1.43200,920 shs$49.15 million Related Companies Tevogen Bio Stock Chart Annexon Stock Chart Foghorn Therapeutics Stock Chart Acelyrin Stock Chart Design Therapeutics Stock Chart UroGen Pharma Stock Chart Cardiff Oncology Stock Chart Canopy Growth Stock Chart ProKidney Stock Chart Genfit Stock Chart Receive OTLK Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Outlook Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:OTLK) was last updated on 6/10/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored"I'm risking my reputation on this"Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the sa...Crypto 101 Media | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored“Biggest Social Security Change Ever”The Financial Times called this new Trump initiative "a big pot of money for the American people." And The Mot...InvestorPlace | SponsoredTrump’s Secret WeaponThe Trump-Elon War Could Trigger an Economic Collapse - Here's Your Only Safe Exit This isn't just a war of...American Alternative | SponsoredWhy 2026 will be a disaster for many Americans2025 Market Crash The first-quarter stock crash left investors wondering what lies ahead. Today 50-year Wal...Chaikin Analytics | SponsoredElon’s “Secret Mission”Tesla, SpaceX and Starlink made billions for investors... But a meeting Elon had on March 21st, 2025, could...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Outlook Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Outlook Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy OTLK Stock Free OTLK Stock Alerts